The efficacy of low-level 940 nm laser therapy with different energy intensities on bone healing
Braz. oral res. (Online)
;
31: e7, 2017. tab, graf
Article
Dans Anglais
| LILACS
| ID: biblio-839537
ABSTRACT
Abstract The aim of this study was to evaluate the efficacy of low-level 940 nm laser therapy with energy intensities of 5, 10 and 20 J/cm2 on bone healing in an animal model. A total of 48 female adult Wistar rats underwent surgery to create bone defects in the right tibias. Low-level laser therapy (LLLT) was applied immediately after surgery and on post-operative days 2, 4, 6, 8, 10 and 12 in three study groups with energy intensities of 5 J/cm2, 10 J/cm2 and 20 J/cm2 using a 940 nm Gallium-Aluminium-Arsenide (Ga-Al-As) laser, while one control group underwent only the tibia defect surgery. All animals were sacrificed 4 or 8 weeks post-surgery. Fibroblasts, osteoblasts, osteocytes, osteoclasts and newly formed vessels were evaluated by a histological examination. No significant change was observed in the number of osteocytes, osteoblasts, osteoclasts and newly formed vessels at either time period across all laser groups. Although LLLT with the 10 J/cm2 energy density increased fibroblast activity at the 4th week in comparison with the 5 and 20 J/cm2 groups, no significant change was observed between the laser groups and the control group. These results indicate that low-level 940 nm laser with different energy intensities may not have marked effects on the bone healing process in both phases of bone formation.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Cicatrisation de plaie
/
Régénération osseuse
/
Photothérapie de faible intensité
/
Lasers à semiconducteur
Type d'étude:
Études d'évaluation
/
Étude pronostique
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
Braz. oral res. (Online)
Thème du journal:
Dentisterie
Année:
2017
Type:
Article
/
descriptif de projet
Pays d'affiliation:
Turquie
Institution/Pays d'affiliation:
Karadeniz Technical University/TR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS